Dopamine D3 receptors

G Protein-Coupled Receptors (GPCRs) ttiA Adrenergic Receptor Dopamine D3 Receptor Endothelin A Receptor... 

Scharfetter, J., Chaudhry, H. R., Hornik, K. etal. (1999). Dopamine D3 receptor gene polymorphism and response to clozapine in schizophrenic Pakistani patients. Eur. Neuropsychophar-macol., 10, 17-20. 

Laszy J, Laszlovszky I, Gyertyan I. Dopamine D3 receptor antagonists improve the learning performance in memory-impaired rats. Psychopharmacology (Berl) 2005 179 567-575. 

Gurevich, E. V. Joyce, J. N. (1999). Distribution of dopamine D3 receptor expressing neurons in the human forebrain comparison with D2 receptor expressing neurons. Neuropsychopharmacology 20, 60-80. 

Hue G Decker M., Solomon L, Rye D. (2003). Increased wakefulness and hyper-responsivity to novel environments in mice lacking functional dopamine D3 receptors. In Society for Neuroscience. 

Le Foil, B., Diaz, J., Sokoloff, P. Increased dopamine D3 receptor expression accompanying behavioral sensitization to nicotine in rats. Synapse. 47 176, 2003. 

Le Foil, B., Sokoloff, P., Stark, H., Goldberg, S.R. Dopamine D3 receptor hgands block nicotine-induced conditioned place preferences through a mechanism that does not involve discriminative-stimulus or antidepressant-like effects. Neuropsychopharmacology. 30 720, 2005. 

Acri J., Carter S., Ailing K. et al. Assessment of cocaine-like discriminative stimulus effects of dopamine D3 receptor ligands. Eur. J. Pharmacol. 281 R7, 1995. 

Lamas X., Negus S., Nader M., Mello N. Effects of the putative dopamine D3 receptor agonist 7-OH-DPAT in rhesus monkeys trained to discriminate cocaine from saline. Psychopharmacology. 124 306, 1996. 

Neisewander J.L., Fuchs R.A., Tran-Nguyen L.T., Weber S.M., Coffey G.P., Joyce J.N. Increases in dopamine D3 receptor binding in rats receiving a cocaine challenge at various time points after cocaine self-administration implications for cocaine-seeking behavior. Neuropsychopharmacology. 29 1479, 2004. 

Le Foil B., Frances H., Diaz J., Schwartz J.C., Sokoloff P. Role of the dopamine D3 receptor in reactivity to cocaine-associated cues in mice. Eur. J. Neurosci. 15 2016, 2002. 

Landwehrmeyer B., Mengod G., Palacios J. Dopamine D3 receptor mRNA and binding site in human brain. Mol. Brain Res. 18 187, 1993. 

Cox B., Rosser M., Kozlowski M., Duwe K., Neve R., Neve K. Regulation and functional characterization of a rat recombinant dopamine D3 receptor. Synapse. 21 1, 1995. 

Grundt P., Carlson E.E., Cao J. et al. Novel heterocyclic trans olefin analogues of A- 4-[4-(2,3-dichlorophenyl)piperazin-l-yl]butyl arylcarboxamides as selective probes with high affinity for the dopamine D3 receptor. J. Med. Chem. 48 839, 2005. 

Xi Z.X., Gilbert J.G., Pak A.C., Ashby C.R., Jr., Heidbreder C.A., Gardner E.L. Selective dopamine D3 receptor antagonism by SB-277011 A attenuates cocaine reinforcement as assessed by progressive-ratio and variable-cost-variable-payoff fixed-ratio cocaine self-administration in rats. Eur. J. Neurosci. 21 3427, 2005. 

Gilbert J.G., Newman A.H., Gardner E.L. et al. Acute administration of SB-277011 A, NGB 2904, or BP 897 inhibits cocaine cue-induced reinstatement of drug-seeking behavior in rats role of dopamine D3 receptors. Synapse. 57 17, 2005. 

Xi Z.X., Gilbert J., Campos A.C. et al. Blockade of mesolimbic dopamine D3 receptors inhibits stress-induced reinstatement of cocaine-seeking in rats. Psycho pharmacology (Berlin). 176 57, 2004. 

Pilla M., Perachon S., Sautel F. et al. Selective inhibition of cocaine-seeking behaviour by a partial dopamine D3 receptor agonist. Nature. 400 371, 1999. 

Steen VM, Lovlie R, MacEwan T, McCreadie RG. Dopamine D3-receptor gene variant and susceptibility to tardive... 

Ishiguro H, Okuyama Y, Toru M, Ari-nami T. Mutation and association analysis of the 5 region of the dopamine D3 receptor gene in schizophrenia patients identification of the Ala38Thr polymorphism and suggested association between DRD3 haplotypes and schizophrenia. Mol Psychiatry 2000 5[4] 433—438. 

Malhotra AK, Goldman D, Buchanan RW, Rooney W, Clifton A, Kosmidis MH et al. The dopamine D3 receptor (DRD3) Ser9Gly polymorphism and schizophrenia a haplotype relative risk study and association with clozapine response. Mol Psychiatry 1998 3(1)72-75. 

Segman R, Neeman T, Heresco-Levy U, Finkel B, Karagichev L, Schlafman M et al. Genotypic association between the dopamine D3 receptor and tardive dyskinesia in chronic schizophrenia. Mol Psychiatry 1999 4(3) 247-253. 

Rietschel M, Krauss H, Muller DJ, Schulze TG, Knapp M, Marwinski K et al. Dopamine D3 receptor variant and tardive dyskinesia. Eur Arch Psychiatry Clin Neurosci 2000 250(l) 31-35. 

Lerer B, Segman RH, Fangerau H, Daly AK, Basile VS, Aschauer HN et al. Pharmacogenetics of tardive dyskinesia Combined analysis of 780 patients supports association with dopamine D3 receptor gene Ser9Gly polymorphism. 

Karpa, K. D., Lin, R., Kabbani, N., and Levenson, R. (2000) The dopamine D3 receptor interacts with itself and the truncated D3 splice variant d3nf D3-D3nf interaction causes mislocalization of D3 receptors. Mol. Pharmacol. 58,677-683. 

---